Literature DB >> 9041180

A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17.

N Puget1, D Torchard, O M Serova-Sinilnikova, H T Lynch, J Feunteun, G M Lenoir, S Mazoyer.   

Abstract

Although more than 100 different BRCA1 germ-line mutations have already been identified in breast and/or ovarian cancer families, we report for the first time a deleterious genomic rearrangement in BRCA1. A 1-kb deletion comprising exon 17 was found in a large breast and ovarian cancer family, leading to a frameshift in the mutant mRNA due to the absence of exon 17. This deletion is probably the result of a recombination between two closely related Alu sequences. It was not detected by conventional PCR-based methods involving the genomic screening of the 22 coding exons or reverse transcription-PCR because the transcript without exon 17 is unstable in lymphoblastoid cell lines. Therefore, rearrangements in the BRCA1 gene should be sought in breast/ovarian cancer families in which no mutations have been found by PCR-based methods in the coding region or in the splice sites.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9041180

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  31 in total

1.  Measurement of locus copy number by hybridisation with amplifiable probes.

Authors:  J A Armour; C Sismani; P C Patsalis; G Cross
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

2.  The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations. The BRCA1 Exon 13 Duplication Screening Group.

Authors: 
Journal:  Am J Hum Genet       Date:  2000-05-25       Impact factor: 11.025

3.  Distinct BRCA1 rearrangements involving the BRCA1 pseudogene suggest the existence of a recombination hot spot.

Authors:  Nadine Puget; Sophie Gad; Laure Perrin-Vidoz; Olga M Sinilnikova; Dominique Stoppa-Lyonnet; Gilbert M Lenoir; Sylvie Mazoyer
Journal:  Am J Hum Genet       Date:  2002-03-05       Impact factor: 11.025

4.  High frequency of BRCA1/2 germline mutations in 42 Belgian families with a small number of symptomatic subjects.

Authors:  G Goelen; E Teugels; M Bonduelle; B Neyns; J De Grève
Journal:  J Med Genet       Date:  1999-04       Impact factor: 6.318

5.  BRCA2 T2722R is a deleterious allele that causes exon skipping.

Authors:  James D Fackenthal; Luca Cartegni; Adrian R Krainer; Olufunmilayo I Olopade
Journal:  Am J Hum Genet       Date:  2002-07-19       Impact factor: 11.025

6.  The BRCA1 exon 13 duplication in the Swedish population.

Authors:  Barbara Kremeyer; Maria Soller; Kristina Lagerstedt; Paula Maguire; Sylvie Mazoyer; Margareta Nordling; Jan Wahlström; Annika Lindblom
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

7.  Ratio of male to female births in the offspring of BRCA1 and BRCA2 carriers.

Authors:  G Chenevix-Trench; O M Sinilnikova; G Suthers; N Pandeya; S Mazoyer; J F Sambrook; S Goldup; D Goldgar; H T Lynch; G M Lenoir; G Cheetham
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

8.  Low prevalence of BRCA1 exon rearrangements in familial and young sporadic breast cancer patients.

Authors:  David Ellis; Yogen Patel; Shu C Yau; Shirley V Hodgson; Stephen J Abbs
Journal:  Fam Cancer       Date:  2006-05-25       Impact factor: 2.375

9.  Large genomic rearrangement of BRCA1 and BRCA2 genes in familial breast cancer patients in Korea.

Authors:  Ja Young Cho; Dae-Yeon Cho; Sei Hyun Ahn; Su-Youn Choi; Inkyung Shin; Hyun Gyu Park; Jong Won Lee; Hee Jeong Kim; Jong Han Yu; Beom Seok Ko; Bo Kyung Ku; Byung Ho Son
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

10.  The partial tandem duplication of ALL1 (MLL) is consistently generated by Alu-mediated homologous recombination in acute myeloid leukemia.

Authors:  M P Strout; G Marcucci; C D Bloomfield; M A Caligiuri
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.